Bioinformatic Analysis of microRNAs Associated with Chemotherapy-Induced Cognitive Impairment: Integration of Gene

Lucas Volpi Cândido1,2, Marcos Otávio Bueno1,2, Ricardo Cervini1,2

  • 1Curso de Medicina, Universidade Alto Vale do Rio do Peixe (UNIARP), Caçador 89500-199, Brazil.

Biomedicines
|March 28, 2026
PubMed

Insights

MicroRNAs (miRNAs) are linked to chemotherapy-induced cognitive deficits, or chemobrain. Specific miRNAs like miR-155-5p, miR-21-5p, and miR-125b-5p are involved in neuroinflammation and synaptic dysfunction, offering potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Oncology

Background:

  • Cancer treatments, particularly chemotherapy, cause significant neuropsychological changes.
  • These cognitive deficits, termed chemobrain, present a persistent clinical challenge.

Purpose of the Study:

  • Identify microRNAs (miRNAs) associated with chemotherapy-induced cognitive alterations.
  • Map miRNA interaction networks and pinpoint involved biological pathways.
  • Investigate the molecular mechanisms underlying chemobrain.

Main Methods:

  • An integrative review of existing literature.
  • In silico analysis of microRNA roles and interactions.
  • Selection of six experimental studies using animal models.

Main Results:

  • Chemotherapy agents (doxorubicin, cisplatin, methotrexate) induce deficits in memory, attention, and learning.
  • miR-155-5p, miR-21-5p, and miR-125b-5p are implicated in neuroinflammation, oxidative stress, apoptosis, and synaptic dysfunction.
  • miRNAs target key pathways including MAPK, PI3K-Akt, and mTOR, forming a network involved in cellular stress and neuroinflammation.

Conclusions:

  • MicroRNAs play a crucial role in mediating chemotherapy-induced neurocognitive changes.
  • These miRNAs represent potential biomarkers and therapeutic targets for mitigating chemobrain.
  • Further research integrating molecular and behavioral data is needed for clinical applications.